China Pharmaceuticals Industry Profile - ISIC2423

Beijing Zeefer Consulting Ltd.
September 7, 2013
28 Pages - SKU: BJZ5135798
Pharmaceuticals and Healthcare Report - Malaysia - Q3 2014
7/23/2014 | published by: Business Monitor International
Malaysia Pharmaceuticals and Healthcare Report Q3 2014 BMI View: We remain generally optimistic towards Malaysia's commitment to provide better quality andaccess to healthcare, as the government plans to expand and upgrade its hospital network. However, wehave  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Sri Lanka - Q3 2014
7/23/2014 | published by: Business Monitor International
Sri Lanka Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Sri Lanka's pharmaceutical sector has received investment from domestic and foreign - notablyIndian - investors in recent years, as economic growth has picked up and the  |  read more...
USD 1,295
Conference Documentation: Immunogenicity
7/14/2014 | published by: SMI Publishing, Ltd
Conference Documentation: Immunogenicity SMi are launching an Immunogenicity Conference, a two day event designed to become the leaders’ favourite with an ever growing demand for biologic therapeutics in the Pharmaceutical Industry.  |  read more...
USD 788
Pharmaceuticals and Healthcare Report - Czech Republic - Q3 2014
7/23/2014 | published by: Business Monitor International
Czech Republic Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Pharmaceutical sales will decline further this year, following the release of poor sales datafrom the first quarter. Price declines throughout Europe and restructuring of the healthcare  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Denmark - Q3 2014
7/23/2014 | published by: Business Monitor International
Denmark Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Like many other Western European countries, Denmark's expanding elderly population willensure that demand for quality healthcare remains high and will be a key driving factor for its  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - United Arab Emirates - Q3 2014
7/23/2014 | published by: Business Monitor International
United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2014 BMI View: The UAE is one of the more developed markets in the Middle East and has a strong existinghealthcare infrastructure. As the UAE is aiming to  |  read more...
USD 1,295
Conference Documentation: Lyophilisation
7/7/2014 | published by: SMI Publishing, Ltd
Conference Documentation: Lyophilisation With increasing numbers of proteins being discovered, the importance of lyophilisation is coming to the fore, for example, as a means of extending the shelf life of pharmaceutical and biopharmaceutical products.  |  read more...
USD 788
Conference Documentation: European BioNetworks Summit
7/7/2014 | published by: SMI Publishing, Ltd
Conference Documentation: European BioNetworks Summit As many products come off patent, this is causing ‘game-changing' falls in revenues. Consequently, industry is grappling with questions pertaining to the most effective strategies for developing meaningful new  |  read more...
USD 788
Pharmaceuticals and Healthcare Report - Cambodia and Laos Q3 2014
7/11/2014 | published by: Business Monitor International
Cambodia and Laos Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Cambodia continues to lag behind its regional peers in terms of investment in healthcareservices. As a result, we maintain that multinational pharmaceutical firms will choose  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Venezuela Q3 2014
7/11/2014 | published by: Business Monitor International
Venezuela Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Price controls, high inflation, currency devaluation, import and foreign currency controls, aswell as other structurally distorting policies in Venezuela will continue to plague the country'spharmaceutical market until  |  read more...
USD 1,295
 

SELECT A LICENSE

    Online Download  USD 580  
    Global Site License  USD 1,450  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!